DI TOMMASO, VALERIA
 Distribuzione geografica
Continente #
NA - Nord America 2.260
AS - Asia 1.253
EU - Europa 1.206
SA - Sud America 196
AF - Africa 31
Continente sconosciuto - Info sul continente non disponibili 25
Totale 4.971
Nazione #
US - Stati Uniti d'America 2.185
SG - Singapore 438
CN - Cina 425
UA - Ucraina 175
BR - Brasile 168
IE - Irlanda 168
IT - Italia 135
GB - Regno Unito 133
RU - Federazione Russa 131
TR - Turchia 129
DE - Germania 124
VN - Vietnam 118
SE - Svezia 113
FR - Francia 106
FI - Finlandia 63
IN - India 52
CA - Canada 29
MX - Messico 15
HK - Hong Kong 14
AR - Argentina 10
JP - Giappone 10
NL - Olanda 10
PL - Polonia 10
BD - Bangladesh 9
CZ - Repubblica Ceca 9
ZA - Sudafrica 9
CH - Svizzera 8
CR - Costa Rica 8
IL - Israele 8
TT - Trinidad e Tobago 8
AE - Emirati Arabi Uniti 7
EC - Ecuador 7
MA - Marocco 7
ES - Italia 6
IQ - Iraq 6
BE - Belgio 5
ID - Indonesia 5
NP - Nepal 5
SC - Seychelles 5
EU - Europa 4
IR - Iran 4
KE - Kenya 4
PK - Pakistan 4
SA - Arabia Saudita 4
CL - Cile 3
ET - Etiopia 3
KR - Corea 3
LT - Lituania 3
NI - Nicaragua 3
PH - Filippine 3
PY - Paraguay 3
CO - Colombia 2
DO - Repubblica Dominicana 2
GP - Guadalupe 2
GR - Grecia 2
GT - Guatemala 2
JO - Giordania 2
OM - Oman 2
SV - El Salvador 2
TN - Tunisia 2
UY - Uruguay 2
AT - Austria 1
AZ - Azerbaigian 1
BH - Bahrain 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
EG - Egitto 1
HN - Honduras 1
HR - Croazia 1
HT - Haiti 1
JM - Giamaica 1
MD - Moldavia 1
MY - Malesia 1
PR - Porto Rico 1
RS - Serbia 1
SY - Repubblica araba siriana 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 4.951
Città #
Singapore 310
Jacksonville 238
Chandler 218
San Jose 192
Dublin 167
Ashburn 154
Beijing 124
Dallas 124
Southend 106
Council Bluffs 99
Nanjing 83
Princeton 82
New York 65
Izmir 64
The Dalles 54
Los Angeles 51
Ho Chi Minh City 45
Santa Clara 43
Cambridge 39
Munich 38
Dearborn 37
Hanoi 36
Buffalo 34
Altamura 28
Nanchang 28
Tongling 28
Moscow 26
Wilmington 26
Ann Arbor 20
São Paulo 17
Shenyang 16
Washington 16
Norwalk 15
Hong Kong 14
Turku 14
Denver 13
North Bergen 13
Grevenbroich 12
Tianjin 12
Carrboro 11
Montreal 11
Brooklyn 10
Chieti 10
Helsinki 10
Jinan 10
Kunming 10
Redondo Beach 10
Frankfurt am Main 9
Mexico City 9
Rio de Janeiro 9
Stockholm 9
Chicago 8
Orem 8
Tokyo 8
Torino 8
Toronto 8
Warsaw 8
Amsterdam 7
Atlanta 7
Brno 7
Camerino 7
Charlotte 7
Fermo 7
Guangzhou 7
Hebei 7
Houston 7
Jiaxing 7
Lanzhou 7
Monmouth Junction 7
Phoenix 7
Boardman 6
Campobasso 6
Falls Church 6
Fribourg 6
Hangzhou 6
Johannesburg 6
Leawood 6
Manchester 6
Queens 6
San José 6
Brasília 5
Changsha 5
London 5
San Francisco 5
Ardabil 4
Belo Horizonte 4
Bologna 4
Brussels 4
Changchun 4
Da Nang 4
Montesilvano Marina 4
Palermo 4
Poplar 4
Salvador 4
San Mateo 4
Augusta 3
Baghdad 3
Biên Hòa 3
Borgomanero 3
Boston 3
Totale 3.097
Nome #
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone 176
Increasing age at disability milestones among MS patients in the MSBase Registry 162
Alemtuzumab treatment of multiple sclerosis in real-world clinical practice: A report from a single Italian center 162
Convulsive status epilepticus due to new encephalic demyelinating lesions in multiple sclerosis 152
An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care. 152
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome. 150
A difficult pediatric case: ADEM evolving in multiple sclerosis complicated by progressive multifocal leukoencephalopathy after Natalizumab treatment. 148
Metabolomics analysis of cerebrospinal fluid reveals a distintive biochemical alteration associated with multiple sclerosis. 147
Anti-JCV serostatus, index value and clinical features in patients affected by multiple sclerosis. 145
Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study 140
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy. 139
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry. 137
Effect of the disclosure of MS diagnosis on anxiety, mood and quality of life of patients: a prospective study 137
JCV-Ab serostatus in MS patients treated with Natalizumab 133
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis. 133
Nail loss after teriflunomide treatment: a new potential adverse event 132
Breastfeeding is not related to postpartum relapses in multiple sclerosis. 131
Natalizumab-associated PML-IRIS: the Chieti experience. 126
Multiphasic Adem or Multiple Sclerosis? Treatement implications. 124
Pregnancy outcomes and disease activity after exposure to natalizumab in patients with multiple sclerosis 118
Pregnancy outcomes and disease activity after exposure to natalizumab in patients with multiple sclerosis 118
Neuropsychological testing and quantitative electroencephalography: a search of neurophysiological markers of cognitive decline in multiple sclerosis 117
Patient adherence to and tolerability of self-administered interferon beta-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study 116
Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis 116
Intramedullary Spinal Cord Glioblastoma: An Uncommon Diagnosis 116
Epidural analgesia and caesarean delivery are not associated with post-partum relapses and disability in MS. 116
Prevalence of JC virus antibodies in human serum and seroconversion rate with first-generation and second generation ELISA: the novel assay improves specificity andsensitivity to detect anti-JC virus antibodies 115
Epidural analgesia and caesarean delivery are not associated with post-partum relapses and disability in MS 114
Atypical presentation of Cadasil a diagnostic challenge 113
Pregnancy and fetal outcomes after Glatiramer acetate exposure in patients with Multiple Sclerosis 105
Treatment discontinuation issues in fingolimod treated patients: the Chieti experience. 105
Progressive multifocal leukoencephalopathy associated with natalizumab in paediatric multiple sclerosis 102
Tumor necrosis factor α blockade therapy in a case of resistant primary angiitis of the central nervous system 102
Stratify-2 Test in the clinical practice: results from a large multicentric italian database 102
Increased risk of disability progression after pregnancy in MS patients with active disease 100
Neuropsychological testing and event-related potentials: markers of cognitive impairment in patients with multiple sclerosis 99
Pregnancy does not prevent disease re-activation after natalizumab suspension in patients with multiple sclerosis 99
Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs 94
Predictors of post-partum relapses and disability progression in Multiple Sclerosis 94
Spinal cord injury in a patient with multiple sclerosis (MS) with secondary hydromyelia 84
Totale 4.971
Categoria #
all - tutte 19.805
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.805


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022121 0 0 0 0 6 5 12 13 8 6 25 46
2022/2023545 43 92 28 44 68 110 33 28 67 8 14 10
2023/2024326 16 21 25 11 31 146 40 0 1 7 3 25
2024/2025661 43 68 66 3 7 23 20 34 51 46 135 165
2025/20261.513 134 39 192 243 181 57 218 65 171 114 84 15
2026/2027417 27 68 80 170 72 0 0 0 0 0 0 0
Totale 4.971